Seppic: Clinical Trials

4 trials sponsored by Seppic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 unknown. 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 14Completed 3, Unknown 1

Follow Seppic: new trials by email

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy Adults
Glycovax-002 - SARS-CoV-2
Phase 1UnknownGlycovax Pharma Inc.362023-04-282024-09-24
Clinical Trial to Study the COVAC-2 Booster Dose (for COVID-19) in Generally Healthy Adults.
COVAC-2, Saline Placebo - Double Vaccinated for COVID-19 (For Phase 1 of the Study), Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)
Phase 1CompletedUniversity of Saskatchewan602022-07-222024-05-03
A Clinical Trial of COVAC-2 in Healthy Adults
COVAC-2, Saline Placebo - Severe Acute Respiratory Syndrome Coronavirus 2
Phase 1CompletedUniversity of Saskatchewan612021-02-102023-05-19
Assessment of Three Formulations of the Candidate Vaccine AMA 1 in Healthy Dutch Adult Volunteers
PfAMA-1-FVO[25-545] - Plasmodium Falciparum Malaria
Phase 1CompletedEuropean Vaccine Initiative562005-11-012008-08-08

Conditions studied

COVID-19 (1)  ·  Malaria, Falciparum (1)

Interventions

COVAC-1 COVID-19 vaccine (2)

Countries

Canada (2)  ·  Australia (1)  ·  Netherlands (1)

Top investigators

Joanne M Langley, MD (1)  ·  Kristi McLendon, MD (1)  ·  Robert Sauerwein, Prof. MD (1)

Results publications

PMID 38769033, PMID 19093004, PMID 22768052, PMID 42268674